maraciclatide

Non-Invasive Scan Shows Promise for Endometriosis Diagnosis in Oxford Trial

A trial at the University of Oxford has shown that an experimental radiotracer called maraciclatide can successfully detect endometriosis through a non-invasive scan. The study of 19 women found the scan aligned with surgical diagnosis in 16 cases with no false positives. Currently, women in England wait an average of 9 years 4 months for diagnosis, which requires invasive surgery. If confirmed in larger trials, the scan could transform diagnosis and treatment of this condition affecting one in 10 women.